Literature DB >> 1969658

Structure, function, and regulation of the interleukin-2 receptor and identification of a novel immune activation gene.

W J Leonard1, J R Gnarra, M Napolitano, M Sharon.   

Abstract

This chapter is divided into two sections, the first dealing with a novel immune activation gene, denoted Act-2. This gene encodes a secreted protein that may represent a new cytokine. The Act-2 protein shares significant homology with proteins in two related families of small secreted proteins. Act-2 is rapidly synthesized by activated T cells, B cells and monocytes. The second section deals with interleukin-2 receptors. These receptors are now known to be comprised of three distinct classes of receptors, formed by various combinations of two IL-2 binding proteins, the alpha and beta chains. The low-affinity receptors contain alpha, but not beta chains; the intermediate-affinity receptors contain beta, but not alpha chains, and the high-affinity receptors contain both alpha and beta chains. The beta chain appears to be tyrosine phosphorylated. We discuss evidence for the existence of another protein of relative molecular mass 100,000, which appears to be a subunit of at least the high-affinity receptor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1969658     DOI: 10.1098/rstb.1990.0053

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  3 in total

1.  Expression on cells of early human pregnancy decidua, of the p75, IL-2 and p145, IL-4 receptor proteins.

Authors:  P M Starkey
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

2.  Increase in gamma interferon-secreting CD8(+), as well as CD4(+), T cells in lungs following aerosol infection with Mycobacterium tuberculosis.

Authors:  C G Feng; A G Bean; H Hooi; H Briscoe; W J Britton
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

3.  Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model.

Authors:  Chi-Young Chang; Jienny Lee; Eun-Young Kim; Hae-Jung Park; Choon-Hyuck Kwon; Jae-Won Joh; Sung-Joo Kim
Journal:  BMC Cancer       Date:  2007-05-23       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.